120 related articles for article (PubMed ID: 38682454)
1. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
[TBL] [Abstract][Full Text] [Related]
2. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
[TBL] [Abstract][Full Text] [Related]
3. Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation.
Haller F; Moskalev EA; Kuck S; Bieg M; Winkelmann C; Müller SK; Ihrler S; Märkl B; Eils R; Wiemann S; Iro H; Hartmann A; Agaimy A
Am J Surg Pathol; 2020 Sep; 44(9):1290-1292. PubMed ID: 32341238
[No Abstract] [Full Text] [Related]
4. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.
Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY
Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350
[TBL] [Abstract][Full Text] [Related]
5. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
[TBL] [Abstract][Full Text] [Related]
6. The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland.
Andreasen S; Varma S; Barasch N; Thompson LDR; Miettinen M; Rooper L; Stelow EB; Agander TK; Seethala RR; Chiosea SI; Homøe P; Wessel I; Larsen SR; Erentaite D; Bishop JA; Ulhøi BP; Kiss K; Melchior LC; Pollack JR; West RB
Am J Surg Pathol; 2019 Apr; 43(4):489-496. PubMed ID: 30520817
[TBL] [Abstract][Full Text] [Related]
7. NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
Richardson ET; Selenica P; Pareja F; Cin PD; Hanlon E; Weigelt B; Reis-Filho JS; Hornick JL; Jo VY; Schnitt SJ
Mod Pathol; 2023 Jun; 36(6):100144. PubMed ID: 36828363
[TBL] [Abstract][Full Text] [Related]
8. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
[TBL] [Abstract][Full Text] [Related]
9. NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma.
Shi Q; Zhang B; Bsirini C; Li L; Giampoli EJ; Magliocca KR; Reid M; Zhou Z
Hum Pathol; 2022 Sep; 127():86-91. PubMed ID: 35700750
[TBL] [Abstract][Full Text] [Related]
10. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
[TBL] [Abstract][Full Text] [Related]
11. [Expression of NR4A3/NOR-1 in acinic cell carcinoma of the salivary gland].
Cheng K; Wang X; Wei X; Ma J; Xia QY; Shi QL; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1142-1146. PubMed ID: 33152819
[No Abstract] [Full Text] [Related]
12. Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
Barasch N; Gong X; Kwei KA; Varma S; Biscocho J; Qu K; Xiao N; Lipsick JS; Pelham RJ; West RB; Pollack JR
PLoS One; 2017; 12(2):e0171265. PubMed ID: 28212443
[TBL] [Abstract][Full Text] [Related]
13. NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens.
Viswanathan K; Beg S; He B; Zhang T; Cantley R; Lubin DJ; Shi Q; Maleki Z; Asiry S; Rao R; Katabi N; Nakaguro M; Faquin WC; Sadow PM; Siddiqui MT; Scognamiglio T
Am J Clin Pathol; 2022 Jan; 157(1):98-108. PubMed ID: 34508546
[TBL] [Abstract][Full Text] [Related]
14. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
[TBL] [Abstract][Full Text] [Related]
15. Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland.
Hsieh MS; Chou YH; Yeh SJ; Chang YL
Virchows Arch; 2015 Aug; 467(2):145-53. PubMed ID: 25976476
[TBL] [Abstract][Full Text] [Related]
16. Analysis of clinicopathologic features and expression of NR4A3 in sinonasal acinic cell carcinoma.
Wang H; Zhai C; Zhang C; Liu Q; Zhang H; Sun X; Lin L; Yu H; Wang D
Mod Pathol; 2022 May; 35(5):594-600. PubMed ID: 34873305
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
18. Head and Neck Acinic Cell Carcinoma: A New Grading System Proposal and Diagnostic Utility of NR4A3 Immunohistochemistry.
Xu B; Saliba M; Ho A; Viswanathan K; Alzumaili B; Dogan S; Ghossein R; Katabi N
Am J Surg Pathol; 2022 Jul; 46(7):933-941. PubMed ID: 35034042
[TBL] [Abstract][Full Text] [Related]
19. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma.
Chiosea SI; Griffith C; Assaad A; Seethala RR
Am J Surg Pathol; 2012 Mar; 36(3):343-50. PubMed ID: 22301503
[TBL] [Abstract][Full Text] [Related]
20. Expanding the Spectrum of NR4A3 Fusion-Positive Gynecologic Leiomyosarcomas.
Momeni-Boroujeni A; Mullaney K; DiNapoli SE; Leitao MM; Hensley ML; Katabi N; Allison DHR; Park KJ; Antonescu CR; Chiang S
Mod Pathol; 2024 May; 37(5):100474. PubMed ID: 38508521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
